Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Grants to Canada Healthcare Organizations, Schools, Associations, and Agencies to Improve the Lives of Women with Breast Cancer

Quality Improvement Grant - Improving the Care of Patients Living With Metastatic Breast Cancer

GrantWatch ID# 196037
Agency: Corporation

Funding Source
Pfizer Global Medical Grants (GMG)
Rethink Breast Cancer
Array ( )

Geographic Focus
Canada:Alberta;   British Columbia;   Manitoba;   New Brunswick;   Newfoundland and Labrador;   Northwest Territories;   Nova Scotia;   Nunavut;   Ontario;   Prince Edward Island;   Quebec;   Saskatchewan;   Yukon;

Important Dates
Deadline: 03/23/23 11:59 PM Eastern Time Save

Grant Description
Grants to Canada healthcare organizations, health professional schools, professional associations, and government agencies to enhance the lives of women living with breast cancer. Funding is intended to improve the quality of care for breast cancer patients who are being treated for metastatic breast cancer (mBC).

Supporting healthcare professionals in their efforts to maintain and improve their knowledge, ability, and performance related to treating patients with mBC is critical to improving patient care. The quality of care that healthcare professionals provide takes place in complex systems that are often in need of analysis and modification to allow for more efficient and effective patient care. In addition, providing resources and education to patients, their caregivers, and family members is crucial to help ensure they are informed and can participate in the shared decision-making process.

Rethink and Pfizer are committed to funding projects that:

  •  Encourage the use of multi-disciplinary care models (e.g. nurse navigators, palliative care, psychological/mental health support)
  • Address disparities in mBC related care for those marginalized due to age, race, income or other factors (equity, diversity, inclusion, accessibility)
  • Use real world evidence to improve quality of care for mBC patients
  • Facilitate healthcare systems and providers to engage patients, their caregivers and families in shared decisionmaking
  • Optimize patient care by improving access to precision medicine and/or alternative diagnostic tools (e.g., liquid biopsy), and throughout the patient cancer experience, including access to clinical trials and evidence-based treatment.
  • Include metastatic breast cancer patients as members of the research team where their perspectives and involvement will be valued
  • Provide sustainable solutions that both improve quality of care for mBC patients and optimally can be utilized or easily implemented in a host of other settings

Multiple factors contribute to the complexity of treating the disease including:

  • The need for cross-functional involvement in care
  • The rapidly changing options for personalizing treatment strategies, including access to precision medicine and alternative diagnostic tools
  • Managing treatment and disease side effects
  • Communicating with patients, caregivers and family members about quality of life and end-of-life decisions and other obstacles patients face when living with the disease.

For topics of interest for this RFP, see


Additional Eligibility Criteria
Eligible Applicants:
- Only organizations are eligible to receive grants, not individuals or medical practice groups.
- The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations; government agencies; and other entities with a mission related to healthcare improvement.
- Canadian health care institutions, large and small; health care professional organizations and other organizations with a mission related to healthcare improvement
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions / organizations / associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- Efforts to increase representation of diverse populations within the team(s) responding to this RFP and those designing projects that are participatory and collaborative [inclusion of voices within the communities most impacted by disparities] are encouraged.

It is not the funding source's intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Pre-Application Information
Key Dates:
• RFP release date: January 23rd, 2023
• Full proposal due date: March 23rd, 2023
Please note the deadline is 23:59 Eastern Time (New York, GMT -5)
• Review of Full Proposals by Review Panel: April 2023
• Anticipated Full Proposal Notification Date: by May 31st, 2023
• Grants will be distributed following a fully executed agreement
• Anticipated Project Start and End Dates: September 2023 to December 2025

All applicants will be notified via email by the dates noted above.

Applicants may be asked for additional clarification during the review period.

Additional Funding Information

Estimated Total Program Funding:


Estimated Size of Grant
Individual projects requesting up to $100,000 will be considered.

Term of Contract
Anticipated Project Start and End Dates: September 2023 to December 2025

Contact Information
Apply online:

If you encounter any technical difficulties with the website, please click the “Technical Questions” link at the bottom of the page.

If you have questions regarding this RFP, please direct them in writing to the Grant Officer,, with the subject line “[2022 Oncology CAN: RethinkPfizer metastatic breast cancer and 27 January 2022].”

Grant Writers For Hire - Grant Writer Team Grant News Grant Writers For Hire - Grant Writer Team
Live Chat Chat Now